Lihat Juga

• Fragmentation of Nimotuzumab for Preparation of 125I-F(ab’)2-Nimotuzumab as a Precursor for Preparing 125I-F(ab’)2-Nimotuzumab-NLS Radiopharmaceutical for Cancer Therapy
  oleh: Haryuni, R.D.; Department of Pharmacy, Faculty of Pharmacy, University of Indonesia, Depok 16424, Indonesia Centre for Radioisotopes and Radiopharmaceuticals Technology, National Nuclear Energy Agency, Puspiptek Area Serpong, Tangerang 15310, Indonesia, et al.
  Terbitan: (2014)
• Fragmentation of nimotuzumab for preparation of 125I-F(ab)2 nimotuzumab as a precursor for preparing
  oleh: HARYUNI, R.D [et. al]
  Terbitan: (2014)
• Preparasi dan Uji Stabilitas 177Lu-DOTA-F(ab�)2- Nimotuzumab Sebagai Kandidat Radiofarmaka Terapi Kanker
  oleh: Citra Rezza Aurora Putri Palangka
• Preparasi Dan Uji Stabilitas 177 LU-Dota-Pamam G3-Nimotuzumab Sebagai Kandidait Radiofarmaka Terapi Kanker
  oleh: Vanji Ikhsan Azis
  Terbitan: (2013)
• Preparation of (177Lu-DOTA)n-PAMAM-[Nimotuzumab-F(ab’)2] as a Therapeutic Radioimmunoconjugate for EGFR Overexpressed Cancers Treatment
  oleh: Humani, Titis Sekar; Center for Radioisotope and Radiopharmaceutical Technology, National Nuclear Energy Agency Indonesia Nuclear Energy Agency (BATAN), et al.
  Terbitan: (2017)